The Cell and Gene Therapy Catapult (CGT Catapult) presented the data in its UK 2024 Advanced Therapy Medicinal Product (ATMP) Clinical Trials Database. The UK maintained its position as a highly ...

Cases of secondary tumors have been reported as a possible adverse reaction to the treatment of certain blood cancers with CAR T-cells. A recent analysis of the cases reported to the ...

There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.

As of March 2018, 10 products have received MA in the EU with Chondrocelect ... and FDA's Breakthrough Designation and Regenerative Medicine Advanced Therapy Designation (2017) have been created to ...

Welcome to the Merck & Company Q4 sales and earnings conference call. [Operator instructions] This call is being recorded.

Most products will be classified as vaccines or chemical medicinal products, but some products, such as those composed of non-synthetic nucleic acids, are considered an advanced therapy medicinal ...

This rising trend mirrors the evolution of the pharmaceutical industry in terms of investment and utilisation of novel ...

the first approval of an allogeneic T-cell therapy in the world. Following a positive recommendation from Europe’s Committee for Medicinal Products for Human Use (CHMP), the European Commission ...

Results of a recent study provided insight into the training needs of nurses involved in the use of advanced therapy medicinal products (ATMPs). The findings were reported in the journal Clinical ...

The Public Health Ministry has established a committee for monitoring and evaluating advanced therapy medicinal products (ATMPs) to further boost treatment efficiency and offer treatment alternatives ...